Valo Health to Participate in Barclays and Oppenheimer Healthcare Investor Conferences

Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs Details of Initial Therapeutic Programs to be Shared at the 39th J.P. Morgan Healthcare Conference

Valo Announces Exclusive Partnership with G3 the World's Largest and Detailed Cardio-Metabolic Datasets

Valo Health Expands Global Operations With Key Leadership in Tel Aviv

Valo Health Adds Award-Winning Neurobiologist Virginie Buggia-Prevot Ph.D. and Computational Scientist Andrea Rossi Ph.D.

Flagship Pioneering Announces Valo Health to Transform Drug Development